As Rare Disease Day 2026 shines a spotlight on patients [...]

As Rare Disease Day 2026 highlights the challenges faced by [...]

Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]

Lario Therapeutics awarded $2.4M by The Michael J. Fox Foundation [...]

Polaryx Therapeutics, Inc has selected a leading contract research organization [...]

Kidswell Bio and Treehill Partners have launched a US-based regenerative [...]

Hansa Biopharma has reported a 135% increase in fourth-quarter revenue [...]

BOOST Pharma has appointed Hans Schambye as its new chief [...]

The Rainwater Charitable Foundation (RCF) has announced the recipients of [...]

Cereno Scientific has broadened the clinical development focus of its [...]